Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
832 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003625 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma | completed | Phase 1 | 7 | Children's Oncology GroupNETWORK | 5 | Jul 28, 2014 | clinicaltrials |
| NCT00003935 | Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | completed | Phase 1 | 31 | Children's Oncology GroupNETWORK | 6 | Jul 28, 2014 | clinicaltrials |
| NCT00621725 | Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours | completed | Phase 1 | 36 | AstraZenecaINDUSTRY | 2 | Jul 15, 2014 | clinicaltrials |
| NCT00265135 | A Study of CNTO 328 in Subjects With Metastatic Renal Cell Carcinoma | completed | Phase 1 / Phase 2 | 68 | Centocor, Inc.INDUSTRY | 4 | Jul 3, 2014 | clinicaltrials |
| NCT00879866 | EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 15 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Jun 23, 2014 | clinicaltrials |
| NCT01903681 | Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances | completed | Phase 1 | 16 | Neurim Pharmaceuticals Ltd.INDUSTRY | 1 | Apr 4, 2014 | clinicaltrials |
| NCT00838370 | Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines | completed | Phase 1 | 22 | The Netherlands Cancer InstituteOTHER | 1 | Mar 4, 2014 | clinicaltrials |
| NCT01241682 | Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma(PMR-MM-002) | completed | Phase 1 | 10 | Erasmus Medical CenterOTHER | 1 | Feb 27, 2014 | clinicaltrials |
| NCT00004932 | STI571 in Treating Patients With Recurrent Leukemia | completed | Phase 1 | 31 | Children's Oncology GroupNETWORK | 7 | Feb 21, 2014 | clinicaltrials |
| NCT00006024 | Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma | completed | Phase 1 | 32 | Children's Oncology GroupNETWORK | 7 | Feb 13, 2014 | clinicaltrials |
| NCT01639885 | Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer(CHIP) | completed | Phase 1 / Phase 2 | 15 | Leiden University Medical CenterOTHER | 1 | Jan 7, 2014 | clinicaltrials |
| NCT01527929 | Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment | completed | Phase 1 | 25 | SanofiINDUSTRY | 5 | Dec 4, 2013 | clinicaltrials |
| NCT01000376 | Evaluating the Pharmacokinetics and Tolerance of Co-administration of Oral Multiple Dose of Ketoconazole and an IV (Bolus) Infusion of Eribulin in Patients With Advanced Solid Tumors | completed | Phase 1 | 12 | Eisai LimitedINDUSTRY | 1 | Sep 23, 2013 | clinicaltrials |
| NCT00028847 | Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia | unknown | Phase 1 / Phase 2 | 60 | Commissie Voor Klinisch Toegepast OnderzoekOTHER | 2 | Sep 17, 2013 | clinicaltrials |
| NCT01079286 | Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers(I-NET) | completed | Phase 1 | 18 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jul 15, 2013 | clinicaltrials |
| NCT00009698 | Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia | completed | Phase 1 | 1 | Children's Oncology GroupNETWORK | 6 | Jun 28, 2013 | clinicaltrials |
| NCT00909402 | A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas | completed | Phase 1 | 39 | Bristol-Myers SquibbINDUSTRY | 4 | Jun 21, 2013 | clinicaltrials |
| NCT01313598 | GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid Tumors | completed | Phase 1 | 20 | Lakefront Biotherapeutics NVINDUSTRY | 1 | Jun 11, 2013 | clinicaltrials |
| NCT00420485 | Dose-escalation Study of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid Tumors | completed | Phase 1 | 120 | Novartis PharmaceuticalsINDUSTRY | 7 | Apr 19, 2013 | clinicaltrials |
| NCT00828594 | Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma | terminated | Phase 1 | 130 | Novartis PharmaceuticalsINDUSTRY | 5 | Apr 11, 2013 | clinicaltrials |
| NCT00297089 | A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 165 | AbbVie (prior sponsor, Abbott)INDUSTRY | 6 | Jan 31, 2013 | clinicaltrials |
| NCT00006357 | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | 91 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00098943 | NGR-TNF in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 70 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Sep 24, 2012 | clinicaltrials |
| NCT00128700 | Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | completed | Phase 1 / Phase 2 | 20 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00068757 | Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer | completed | Phase 1 | 23 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 12, 2012 | clinicaltrials |
| NCT00948389 | Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM) | terminated | Phase 1 / Phase 2 | 28 | Bristol-Myers SquibbINDUSTRY | 4 | Aug 31, 2012 | clinicaltrials |
| NCT00660153 | Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers | completed | Phase 1 | 30 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 28, 2012 | clinicaltrials |
| NCT00027677 | Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors | completed | Phase 1 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jul 24, 2012 | clinicaltrials |
| NCT00838240 | Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia(AML-14A) | unknown | Phase 1 / Phase 2 | 114 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 20, 2012 | clinicaltrials |
| NCT00591136 | Phase I Study of Indibulin in Patients With Solid Tumors | completed | Phase 1 | 47 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 19, 2012 | clinicaltrials |
| NCT00004015 | Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery | completed | Phase 1 | 36 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Jul 18, 2012 | clinicaltrials |
| NCT00005061 | Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 20 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Jul 18, 2012 | clinicaltrials |
| NCT00003976 | E7070 in Treating Patients With Solid Tumors | completed | Phase 1 | 30 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00003979 | CHS 828 in Treating Patients With Solid Tumors | withdrawn | Phase 1 | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00003980 | BIBX 1382 in Treating Patients With Solid Tumors | suspended | Phase 1 | 80 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00003981 | E7070 in Treating Patients With Solid Tumors | completed | Phase 1 | 30 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00003982 | MEN-10755 in Treating Patients With Solid Tumors | completed | Phase 1 | 30 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00003985 | KRN7000 in Treating Patients With Solid Tumors | withdrawn | Phase 1 | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00002904 | Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors | completed | Phase 1 | 40 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT00003028 | MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 5 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT00863850 | Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy | completed | Phase 1 | 6 | CephalonINDUSTRY | 1 | Apr 23, 2012 | clinicaltrials |
| NCT00982631 | A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer | unknown | Phase 1 | 30 | Radboud University Medical CenterOTHER | 1 | Apr 11, 2012 | clinicaltrials |
| NCT00706095 | Study Of Eribulin (E7389) In Patients With Advanced Solid Tumors And Normal Or Reduced Hepatic Function As Per Child-Pugh System | completed | Phase 1 | 18 | Eisai Inc.INDUSTRY | 1 | Mar 27, 2012 | clinicaltrials |
| NCT00860860 | Study of Pretargeted Radioimmunotherapy of a Anti-CEA Bispecific Antibody and Lu177-labeled Peptide in Colorectal Cancer(PRIT2008) | completed | Phase 1 | 20 | Radboud University Medical CenterOTHER | 1 | Mar 19, 2012 | clinicaltrials |
| NCT00908908 | A Study to Determine the Metabolism and Elimination of Carbon-14 Labeled Eribulin Acetate (14C-Eribulin) in Patients With Advanced Solid Tumors | completed | Phase 1 | 6 | Eisai Inc.INDUSTRY | 1 | Mar 9, 2012 | clinicaltrials |
| NCT00737555 | A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours | completed | Phase 1 | 23 | Chroma TherapeuticsINDUSTRY | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00777478 | Capiri-sutent Phase-1 in Advanced Colo-rectal Cancer(sutent-capiri) | unknown | Phase 1 | 32 | Radboud University Medical CenterOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT01031784 | Radioactive Holmium Microspheres for the Treatment of Liver Metastases(HEPAR) | completed | Phase 1 | 15 | UMC UtrechtOTHER | 1 | Jan 31, 2012 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials